Direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy

Strahlentherapie und Onkologie

Volumn 186, Issue 4, 2010, Pages 197-202

  Dolezel, M ^a   Odrazka, Karel ^a   Vaculikova, Miloslava ^b   Vanasek, Jaroslav ^a   Sefrova, Jana ^c   Paluska, Petr ^c   Zouhar, Milan ^c   Jansa, Jan ^c   Macingova, Zuzana ^c   Jarosova, Lida ^c   Brodak, Milos ^c   Moravek, Petr ^c   Hartmann, Igor ^d  

^a Pardubice Regional Hospital   (Czech Republic)

^b Hospital Náchod   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Conformai radiotherapy; Dose escalation; Intensity modulated radiotherapy (IMRT); Prostate cancer

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DIARRHEA; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PROSTATE CANCER; RADIATION DOSE; RADIATION SICKNESS; RATING SCALE; SCORING SYSTEM; SEMINAL VESICLE; UROGENITAL TRACT DISEASE; ACUTE DISEASE; CANCER STAGING; CROSS-SECTIONAL STUDY; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE; PROSTATE TUMOR; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RISK FACTOR; UROGENITAL SYSTEM;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; INCIDENCE; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS; SEMINAL VESICLES; UROGENITAL SYSTEM;

EID: 77951644675     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2065-x     Document Type: Article

References (34)

1. AL-Mamgani A, van Putten WLJ, Heemsbergen WD, et al. Update of the Dutch multicenter dose escalation trial of radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2008;72:980-988
2. Cahlon O, Hunt M, Zelefsky MJ. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol 2008;18:48-57. (Pubitemid 350235956)
3. Cavey ML, Bayouth JE, Colman M, et al. IMRT to escalate the dose to the prostate while treating the pelvic nodes. Strahlenther Onkol 2005;181: 431-441 (Pubitemid 40956579)
4. Dearnaley DP, Hall E, Lawrence D, et al. Phase III pilot study of dose escalation using conformai radiotherapy in prostate cancer: PSA control and side effects. B J Cancer 2005;92:488-498 (Pubitemid 40395529)
5. De Meerleer G, Vakaet L, De Gersem W, et al. Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer. Strahlenther Onkol 2004;180:136-143 (Pubitemid 38313745)
6. Di Muzio N, Fiorino C, Cozzarini C, et al. Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:392-398
7. Dobler B, Mai S, Ross C, et al. Evaluation of possible prostate displacement induced by pressure applied during transabdominal ultrasound image acquisition. Strahlenther Onkol 2006;182:240-246
8. Fiorino C, Dell'Oca I, Pierelli A, et al. Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study. Strahlenther Onkol 2007;183:497-505. (Pubitemid 47347930)
9. Gershkevitsh E, Clark CH, Staffurth J, et al. Dose to bone marow using IMRT techniques in prostate cancer patients. Strahlenther Onkol 2005;181: 172-178
10. Goldner G, Bombosch V, Geinitz H, et al. Moderate risk-adapted dose escalation with three-dimensional conformai radiotherapy of Localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial. Strahlenther Onkol 2009;185:94-100.
11. Goldner G, Wachtner S, Wachtner-Gerstner N, et al. Long-term results in three-dimensional conformai radiotherapy of Localized prostate cancer at moderate dose (66 Gy). Strahlenther Onkol 2006;182:537-542 (Pubitemid 44316243)
12. Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:483-499 (Pubitemid 41059518)
13. Guckenberger M, Flentje M. Intensity-modulated radiotherapy (IMRT) of Localized prostate cancer. Strahlenther Onkol 2007;183:57-62. (Pubitemid 46996070)
14. Guckenberger M, Mayer J, Wilbert J, et al. Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and Limitations in clinical practice. Strahlenther Onkol 2007;183:307-313 (Pubitemid 46996069)
15. Guerrero M, Li XA, Ma L, et al. Simultaneous integrated intensity-modulated radiotherapy boost for Locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys 2005;62:933-939
16. Hanks GE, Hanlon AL, Epstein B, et al. Dose response in prostate cancer with 8-12 years follow-up. Int J Radiat Oncol Biol Phys 2002;54:427-435 (Pubitemid 35286808)
17. Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:67-74. (Pubitemid 350251041)
18. Kupelian PA, Langen KM, Willoughby TR, et al. Image-guided radiotherapy for Localized prostate cancer: treating a moving target. Semin Radiat Oncol 2008;18:58-66. (Pubitemid 350235957)
19. Marks LB, Carroll PR, Dugan TC, et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1257-1280
20. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on Localized prostate carcinoma. Strahlenther Onkol 2005;181:448-455
21. Nairz O, Mery F, Deutschmann H, et al. A strategy for the use of image-guid-ed radiotherapy (IGRT) on Linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol 2008;184: 1874-1877.
22. Nakamatsu K, Suzuki M, Nishimura Y, et al. Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy. Int J Clin Oncol 2008;13:48-53. (Pubitemid 351326282)
23. Odrazka K, Petera J, Zouhar M, et al. Clinical results of intensity-modulated radiation therapy (IMRT) for tumors of the head and neck region. Neoplasma 2005;52:85-94. (Pubitemid 40503409)
24. Odrazka K, Zouhar M, Petera J, et al. Comparison of rectal dose-volume constraints for IMRT prostate treatment planning. Phys Med 2005;21: 129-135
25. Pinkawa M, Purch-Lee M, Asadpour B, et al. Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate Localization for the analysis of inter- and intrafraction organ motion. Strahlenther Onkol 2008;184:679-685
26. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: result of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097-1105 (Pubitemid 34787842)
27. Sanguineti G, Cavey ML, Endres EJ, et al. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformai prostate-only radiotherapy to 76 Gy? Strahlenther Onkol 2006;182:543-549
28. Schulte RW, Slater JD, Rossi CJ, et al. Value and perspectives of proton radiation therapy for Limited stage prostate cancer. Strahlenther Onkol 2000;176:3-8.
29. Sterzing F, Scubert K, Sroka-Perez G, et al. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008;184: 8-14.
30. Teshima T, Hanks GE, Hanlon AL, et al. Rectal bleeding after conformai 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 1997;39:77-83.
31. Wachtner-Gerstner N, Wachtner S, Goldner G, et al. Biochemical response after 3-D conformai radiotherapy of Localized prostate cancer to a total dose of 66 Gy. Strahlenther Onkol 2002;178:542-547
32. Zelefsky MJ, Chan H, Hunt M, et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically Localized prostate cancer. J Urol 2006;176:1415-1419
33. Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformai radiotherapy in patients with Localized prostate carcinoma. Cancer 1999;85:2460-2468 (Pubitemid 29244857)
34. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformai radiation therapy in clinically Localized adenocarcinoma of the prostate: aA randomized controlled trial. JAMA 2005;294:1233-1239 (Pubitemid 41352111)